Search Results - Andrea Rubbert-Roth
- Showing 1 - 13 results of 13
-
1
Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study by Andrea Rubbert-Roth, Koji Kato, Boulos Haraoui, Maureen Rischmueller, Yanxi Liu, Nasser Khan, Heidi S. Camp, Ricardo M. Xavier
Published in Rheumatology and Therapy (2024-07-01)Get full text
Article -
2
Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials... by Andrea Rubbert-Roth, Daniel E. Furst, Stefano Fiore, Amy Praestgaard, Vivian Bykerk, Clifton O. Bingham, Christina Charles-Schoeman, Gerd Burmester
Published in Arthritis Research & Therapy (2022-08-01)Get full text
Article -
3
Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting by Rieke Alten, Harald Burkhardt, Eugen Feist, Klaus Krüger, Juergen Rech, Andrea Rubbert-Roth, Reinhard E. Voll, Yedid Elbez, Christiane Rauch
Published in Arthritis Research & Therapy (2018-01-01)Get full text
Article -
4
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-B... by Roy Fleischmann, Stephen Hall, Bernard Combe, Andrea Rubbert-Roth, Christina Charles-Schoeman, Nasser Khan, Heidi S Camp, Sebastian Meerwein, Kyle M Carter
Published in RMD Open (2024-07-01)Get full text
Article -
5
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials by Gerd R. Burmester, Jayne Stigler, Andrea Rubbert-Roth, Yoshiya Tanaka, Valderilio F. Azevedo, Derek Coombs, Ivan Lagunes, Ralph Lippe, Peter Wung, Lianne S. Gensler
Published in Rheumatology and Therapy (2024-04-01)Get full text
Article -
6
Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis by Andrea Rubbert-Roth, Adriana M. Kakehasi, Tsutomu Takeuchi, Marc Schmalzing, Hannah Palac, Derek Coombs, Jianzhong Liu, Samuel I. Anyanwu, Ralph Lippe, Jeffrey R. Curtis
Published in Rheumatology and Therapy (2023-11-01)Get full text
Article -
7
Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis by Axel Finckh, Kim Lauper, Denis Mongin, Delphine S Courvoisier, Celine Lamacchia, Diego Kyburz, Andrea Rubbert-Roth, Benoît Thomas P Gilbert, Eric Trunk, Olivia Studer, Burkhard Moeller
Published in BMJ Open (2021-07-01)Get full text
Article -
8
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies by Peter C. Taylor, Yun-Fei Chen, Janet Pope, Michael Weinblatt, Eduardo Mysler, Andrea Rubbert-Roth, Bochao Jia, Luna Sun, Yushi Liu, Thorsten Holzkämper, Yoshiya Tanaka
Published in Rheumatology and Therapy (2023-01-01)Get full text
Article -
9
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry by Oliver Distler, Diego Kyburz, Adrian Ciurea, Michael J Nissen, Andrea Rubbert-Roth, Raphael Micheroli, Almut Scherer, Kristina Bürki, Pascale Exer, Burkhard Möller, Michael Andor, René Bräm, Thomas Hügle, Andrea Götschi
Published in RMD Open (2023-11-01)Get full text
Article -
10
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension by Gerd R Burmester, Mark C Genovese, Vibeke Strand, Gregory St John, Andrea Rubbert-Roth, Howard Amital, Tatiana Raskina, Antonio Gómez-Centeno, Claudia Pena-Rossi, Leon Gervitz, Karthinathan Thangavelu, Susan Boklage
Published in RMD Open (2019-10-01)Get full text
Article -
11
Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA by Johannes von Kempis, Andrea Rubbert-Roth, Burkhard Ludewig, Irene A Abela, Magdalena Schwarzmueller, Alexandra Trkola, Sabrina Pagano, Nicolas Vuilleumier, Kristin Schmiedeberg, Natalia Barbara Pikor, Selina Epp, Sarah Grabherr, Angelica Brooke Patterson, Madalina Nussberger
Published in RMD Open (2022-10-01)Get full text
Article -
12
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases by Catherine E. Raptis, Christoph T. Berger, Christoph T. Berger, Adrian Ciurea, Diego O. Andrey, Diego O. Andrey, Christos Polysopoulos, Pierre Lescuyer, Tanja Maletic, Myriam Riek, Almut Scherer, Isabell von Loga, Judith Safford, Kim Lauper, Kim Lauper, Burkhard Möller, Nicolas Vuilleumier, Nicolas Vuilleumier, Axel Finckh, Axel Finckh, Andrea Rubbert-Roth
Published in Frontiers in Immunology (2022-10-01)Get full text
Article -
13
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the r... by Frank Behrens, Jürgen Rech, Jürgen Braun, Denis Poddubnyy, Gerd R Burmester, Uta Kiltz, Stephanie Finzel, Diamant Thaçi, Herbert Kellner, Karolina Benesova, Reinhard E Voll, Jan Brandt, Andrea Rubbert-Roth, David M Kofler, Klaus Krüger, Siegfried Wassenberg, Winfried Demary, Regina Max, Peter Kastner, Michaela Koehm, Ulrich von Hinüber, Raoul Bergner, Jan Brandt-Jürgens, Ann C Foldenauer, Tanja Rossmanith, Maren Sieburg, Rieke HE Alten, Arnd Kleye, David Kofler, Gabriele Lorenz, Holger Schwenke, Astrid Thiele, Jochen Walter
Published in RMD Open (2023-10-01)Get full text
Article